Communicating the benefits and harms of colorectal cancer screening needed for an informed choice: A systematic evaluation of leaflets and booklets

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Dreier, Maren ^a   Borutta, Birgit ^a   Seidel, Gabriele ^a   Münch, Inga ^a   Kramer, Silke ^a   Töppich, Jürgen ^b   Dierks, Marie Luise ^a   Walter, Ulla ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Federal Centre for Health Education BZgA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONSUMER; CONSUMER HEALTH INFORMATION; GERMANY; HEALTH PROMOTION; HUMAN; INFORMATION LITERACY; MASS MEDIUM; MEDICAL ERROR; MEDICAL INFORMATION SYSTEM; OCCULT BLOOD TEST; PRINTING; PUBLICATION; RISK BENEFIT ANALYSIS; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; HEALTH SERVICE; INTERNET; MASS SCREENING; PSYCHOLOGY;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; GERMANY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNET; MASS SCREENING; PUBLICATIONS;

EID: 84925827064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107575     Document Type: Article

References (37)

1. Raffle A, Muir Gray JA (2007) How screening started. In: Screening-Evidence and Practice. New York: Oxford University Press. pp. 1-30.
2. Woloshin S, Schwartz LM, Black WC, Kramer BS (2012) Cancer screening campaigns-getting past uninformative persuasion. N Engl J Med 367: 1677-1679.
3. Eckstrom E, Feeny DH, Walter LC, Perdue LA, Whitlock EP (2013) Individualizing cancer screening in older adults: A narrative review and framework for future research. J Gen Intern Med 28: 292-298.
4. Elmore JG, Fletcher SW (2012) Overdiagnosis in breast cancer screening: Time to tackle an underappreciated harm. Ann Intern Med 156: 536-537.
5. Jorgensen KJ, Zahl PH, Gotzsche PC (2009) Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 9: 36.
6. Austoker J, Giordano L, Hewitson P, Villain P (2012) European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Communication. Endoscopy 44 Suppl 3: SE164-SE185.
7. General Medical Counsil (2008) Consent: patients and doctors making decisions together. Available: http://www.gmc-uk.org/guidance/ethical-guidance/consent-guidance/index asp. Accessed 2014 Jan 12.
8. Bretthauer M, Kalager M (2013) Principles, effectiveness and caveats in screening for cancer. Br J Surg 100: 55-65.
9. Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von SD, et al. (2012) Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 142: 1460-1467.
10. Patera N (2010) Screening for colorectal cancer. Part 1: screening-Tests and program design, HTA project.
11. Coulter A, Ellins J (2007) Effectiveness of strategies for informing, educating, and involving patients. BMJ 335: 24-27.
12. Bunge M, Mühlhauser I, Steckelberg A (2010) What constitutes evidence-based patient information? Overview of discussed criteria. Patient education and counseling 78: 316-328.
13. Jorgensen KJ, Brodersen J, Hartling OJ, Nielsen M, Gotzsche PC (2009) Informed choice requires information about both benefits and harms. J Med Ethics 35: 268-269.
14. Gigerenzer G, Gassmaier W, Kurz-Milcke E, Schwartz L, Woloshin S (2008) Helping Doctors and Patients Make Sense of Health Statistics. Psychological Science in the Public Interest 8: 53-96.
15. Gigerenzer G, Edwards A (2003) Simple tools for understanding risks: from innumeracy to insight. BMJ 327: 741-744.
16. Gigerenzer G (2011) What are natural frequencies? BMJ 343: d6386.
17. Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, et al. (2011) Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev CD006776. 10.1002/14651858.CD006776.pub2 [doi].
18. Nuovo J, Melnikow J, Chang D (2002) Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 287: 2813-2814.
19. Steckelberg A, Balgenorth A, Muhlhauser I (2001) [Analysis of German language consumer information bookllets on screening for colorectal cancer]. Z Arztl Fortbild Qualitatssich 95: 535-538.
20. National Cancer Plan Germany (2012) Aktueller Stand des Nationalen Krebsplans. Handlungsfelder, Ziele und Umsetzungsempfehlungen. Stand: 04. Januar 2012. Available: https://www.webgate.ec.europa.eu/sanco/heidi/images/2/23/Germany-Working-Document-on-NCP-German-4.1.2012.pdf. Accessed 2014 Jan 12.
21. Dreier M, Borutta B, Seidel G, Kreusel I, Toppich J, et al. (2013) Development of a comprehensive list of criteria for evaluating consumer education materials on colorectal cancer screening. BMC Public Health 13: 843.
22. Welch HG, Black WC (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102: 605-613.
23. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981.
24. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update. Am J Gastroenterol 103: 1541-1549.
25. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, et al. (2012) Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: A systematic review and meta-Analysis of randomized controlled trials. PLoS Med 9: e1001352.
26. Heleno B, Thomsen MF, Rodrigues DS, Jorgensen KJ, Brodersen J (2013) Quantification of harms in cancer screening trials: literature review. BMJ 347: f5334.
27. Khazaal Y, Chatton A, Zullino D, Khan R (2012) HON label and DISCERN as content quality indicators of health-related websites. Psychiatr Q 83: 15-27.
28. Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, et al. (2009) Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PloS one 4: e4705.
29. National Cancer Institute. Tests to detect colorectal cancer. 1. What is colorectal cancer. Available: http://www.cancer.gov/cancertopics/factsheet/detection/colorectal-screening. Accessed 2014 Jan 12.
30. van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AH, et al. (2013) What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer 49: 2321-2330.
31. Steckelberg A, Hulfenhaus C, Haastert B, Muhlhauser I (2011) Effect of evidence based risk information on ''informed choice'' in colorectal cancer screening: randomised controlled trial. BMJ 342: d3193.
32. Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, et al. (2010) A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ 341: c5370.
33. Marteau TM, Mann E, Prevost AT, Vasconcelos JC, Kellar I, et al. (2010) Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ 340: c2138
34. Wagner CV (2011) A decision aid to support informed choice about bowel cancer screening in people with low educational level improves knowledge but reduces screening uptake. Evid Based Nurs 14: 36-37.
35. Hirschberg I, Seidel G, Strech D, Bastian H, Dierks ML (2013) Evidence-based health information from the users' perspective-A qualitative analysis. BMC Health Serv Res 13: 405.
36. Smith SK, Trevena L, Barratt A, Dixon A, Nutbeam D, et al. (2009) Development and preliminary evaluation of a bowel cancer screening decision aid for adults with lower literacy. Patient Educ Couns 75: 358-367.
37. Hawkes N (2011) Breast cancer screening is to be reviewed, cancer tsar announces. BMJ 343: d6905.